Cochrane Abstracts
Metrifonate for Alzheimer's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Metrifonate for Alzheimer's Disease." Cochrane Abstracts Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433741/all/Metrifonate_for_Alzheimer's_disease.
Metrifonate for Alzheimer's disease. Cochrane Abstracts Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433741/all/Metrifonate_for_Alzheimer's_disease. Accessed October 5, 2026.
Metrifonate for Alzheimer's disease. (2026). In Cochrane Abstracts Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433741/all/Metrifonate_for_Alzheimer's_disease
Metrifonate for Alzheimer's Disease [Internet]. In: Cochrane Abstracts Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 October 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433741/all/Metrifonate_for_Alzheimer's_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Metrifonate for Alzheimer's disease
ID - 433741
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433741/all/Metrifonate_for_Alzheimer's_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
